Insulin sensitivity, clearance and release in kininogen-deficient rats

Experimental Physiology

Volumn 84, Issue 3, 1999, Pages 549-557

  Damas, Jacques ^a   Bourdon, Victor ^a   Lefebvre, Pierre J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; GLUCOSE; ICATIBANT; INSULIN; KININOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TRANSPORT; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NONHUMAN; PROTEIN DEFICIENCY; RAT;

EID: 0033008728     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0958067099018126     Document Type: Article

References (28)

1. BERNE, C. (1991). Metabolic effects of ACE inhibitors. Journal of Internal Medicine 229, suppl. 2, 119-125.
2. BHOOLA, K. D., FIGUEROA, C. D. & WORTHY, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacological Reviews 44, 1-80.
3. CARVALHO, C. R. O., THIRONE, A. C. P., GONTIJO, J. A. R., VELLOSO, L. A. & SAAD, M. J. A. (1997). Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 46, 1950-1957.
4. CASTILLO, M. J., SCREEN, A. J., LETIEXHE, M. R. & LEFEBVRE, P. J. (1994). How to measure insulin clearance. Diabetes/Metabolism Reviews 10, 119-150.
5. DAMAS, J. (1996). The Brown Norway rats and the kinin system. Peptides 17, 859-872.
6. DAMAS, J., BOURDON, V. & LEFEBVRE, P. J. (1998). Insulin sensitivity of kininogen-deficient rats. Pflügers Archiv 435, R246.
7. DIETZE, G. J. (1982). Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins. Molecular and Cellular Endocrinology 25, 127-149.
8. DONNELLY, R. (1992). Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure. Journal of Cardiovascular Pharmacology 20, suppl. 11, S38-S44.
9. ERLICH, Y. & ROSENTHAL, T. (1998). Contribution of bradykinin to the beneficial effects of ramipril in the fructose-fed rat. Journal of Cardiovascular Pharmacology 31, 581-584.
10. HENRIKSEN, E. J., JACOB, S., FOGT, D. L. & DIETZE, G. J. (1998). Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance. American Journal of Physiology 275, R40-45.
11. KATO, H., ENJYOJI, K. I., MIYATA, T, HAYASHI, I., OH-ISHI, S. & IWANAGA, S. (1985). Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: Direct evidence for liberation of bradykinin by rat glandular kallikreins. Biochemical and Biophysical Research Communications 127, 289-295.
12. KISHI, K., MUROMOTO, N., NAKAYA, Y., MIYATA, I., HAGI, A., HAYASHI, H. & EBINA, Y. (1998). Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47, 550-558.
13. KOHLMAN, O., DE ASSIS ROCHA NEVES, F., GINOZA, M., TAVARES, A., CEZARETTI, M. L., ZANELLA, M. T., RIBEIRO, A. B., GAVRAS, I. & GAVRAS, H. (1995). Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. Hypertension 25, 1003-1007.
14. KOUYOUMDJIAN, M. & DAMAS, J. (1998). The fate of plasma kallikrein in kininogen-deficient rats. Archives of Physiology and Biochemistry 106, 25-32.
15. KRAEGEN, E. W., JAMES, D. E., BENNETT, S. P. & CHISHOLM, D. J. (1983). In vivo insulin sensitivity in the rat determined by euglycemic clamp. American Journal of Physiology 245, E1-7.
16. 1 receptors: a review, Immunopharmacology 30, 1-26.
17. MAYFIELD, R. K., SHIMOJO, N. & JAFFA, A. A. (1996). Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes 45, S20-S23.
18. MIYATA, T., TAGUCHI, T, UEHARA, M., ISARNI, S., KISHIKAWA, H., KANEKO, K., ARAKI, E. & SHICHIRI, M. (1998). Bradykinin potentiates insulin-stimulated uptake and enhances insulin signal through the bradykinin B-2 receptor in dog skeletal muscle and rai L6 myoblasts. European Journal of Endocrinology 138, 344-350.
19. QUABBE, H. J. (1969). Modification der radioimmunologischen Insulinbestimmung nach Hales und Randle. Diabetologia 5, 101-107.
20. REGOLI, D. & BARABE, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacological Reviews 32, 1-46.
21. RETT, K., MEARKER, E., LODRI, C., WICKLMAYR, M. & DIETZE, G. (1986). Effects of kallikrein, bradykinin and insulin on substrate metabolism in the isolated perfused rat heart. Advances in Experimental Medicine and Biology 198 (part b), 379-384.
22. RETT, K., WICKLMAYR, M. & DIETZE, G. (1990). Metabolic effects of kinins: historical and recent developments. Journal of Cardiovascular Pharmacology 15, S57-S59.
23. ROTHSCHILD, A. M., BODEN, G. & COLMAN, R. W. (1996). Kininogen changes in human plasma following test meal or insulin administration. American Journal of Physiology 270, H1071-1077.
24. SCHEEN, A. J. & LEFEBVRE, P. J. (1996). Pathophysiology of type 2 diabetes mellitus. In Handbook of Experimental Pharmacology, vol. 119, Oral Antidiabetics, ed. KUHLMANN, J. & PULS, W., pp. 7-42. Springer, Berlin.
25. TOMIYAMA, H., KUSHIRO, T., ABETA, H., ISHII, T., TAKAHASHI, A., FURUKAWA, L., ASAGAMI, T, HINO, T., SAITO, R, OTSUKA, Y., KURUMATAMI, H., KOBAYASHI, F., KANMATSUSE, K. & KAJIWARA, N. (1994). Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 23, 450-455.
26. WIRTH, K. J., HOCK, F. J., ALBUS, U., LINZ, W., ALPERMANN, H. G., ANAGNOSTOPOULOS, H., HENKE, S., BREIPOHL, G., KONIG, W., KNOLLE, J. & SCHOLKENS, B. A. (1991). HOE 140 a new potent and long acting bradykinin-antagonist. British Journal of Pharmacology 102, 297-304.
27. YANG, C., CHAO, J. & HSU, W. H. (1997). The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas. Metabolism 46, 1113-1115.
28. YANG, C. & HSU, W. H. (1995). Stimulatory effect of bradykinin on insulin release from the perfused rat pancreas. American Journal of Physiology 268, E1027-1030.